Oral contraceptive steroid induced platelet coagulant hyperactivity: Dissociation of in vivo and in vitro effects

Thrombosis Research

Volumn 48, Issue 1, 1987, Pages 41-50

  Huch, Kim M ^a   Elam, Marshall B ^a   Chesney, Carolyn M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

coagulant activity; Oral contraceptives; platelets

Indexed keywords

ESTRADIOL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; STEROID;

BLOOD CLOTTING; FEMALE; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; NORMAL HUMAN; PREVENTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

AMERICAS; BIOLOGY; BLOOD COAGULATION EFFECTS; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; ESTROGENS--SIDE EFFECTS; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; HEMATOLOGICAL EFFECTS; HEMIC SYSTEM; HORMONES; IN VITRO; LABORATORY EXAMINATIONS AND DIAGNOSES; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY; PLATELET AGGREGATION; PROGESTATIONAL HORMONES; PROGESTERONE--SIDE EFFECTS; RESEARCH METHODOLOGY; UNITED STATES;

ADULT; BLOOD COAGULATION; BLOOD PLATELETS; COMPARATIVE STUDY; CONTRACEPTIVES, ORAL; EPINEPHRINE; ESTRADIOL; FEMALE; HUMAN; IN VITRO; MALE; NUCLEOTIDES; OSMOLAR CONCENTRATION; PLATELET AGGREGATION; PROGESTERONE; REFERENCE VALUES; STEROIDS;

EID: 0023553725     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(87)90344-6     Document Type: Article

References (28)

1. Hormonal contraception and thromboembolic disease Effects of oral contraceptives on hemostatic mechanisms; a review of the literature
2. Thromboembolism oral contraceptives and cigarettes
3. Oral contraceptives smoking and other factors in relation to risk of venous thromboembolic disease
4. Thromboembolic disease and the steroidal content of oral contraceptives A report to the committee on safety of drugs
5. Effects of oral contraceptives on blood coagulation
6. Low-dose oral contraceptive usage and coagulation
7. Effect of oral contraceptives on antithrombin III
8. The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma
9. 125I-fibrinogen to rat platelets
10. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives
11. The effect of oral contraceptives on rat platelet membrane glycoproteins
12. Effect of ethinyl-estradiol on arachidonic acid incorporation release and conversion to prostaglandins in rabbit platelets
13. Effect of oral contraceptive use on platelet prothrombin converting (platelet factor 3) activity
14. Influence of pregnancy and oral contraceptives in relation to coagulation and aggregation
15. The function of steroids in membranes
16. Testosterone potentiation of sonophore and ADP induced platelet aggregation: Relationship to arachidonic acid metabolism
17. Vitamin E prevents the platelet abnormalities induced by estrogen in rat
18. Platelet Aggregation
19. Platelet hyperaggregability and thrombosis in patients with thrombocythemia
20. Differentiation of factor V-like coagulant activity from catalytic-like surface activity in membrane fractions derived from human platelets
21. Plasma levels and pharmacokinetics of ethynyl estrogens in various populations I Ethynylestradiol
22. Plasma levels pharmacokinetics of ethynyl estrogens in various populations II Mestranol
23. Plasma levels of progesterone achieved by different routes of administration
24. The platelets membrane as a catalytic surface in thrombin generation Availability of platelet factor 1 and platelet factor 3
25. Platelet phospholipids and their function in patients with ischemic heart disease
26. Platelet coagulant activities and serum lipids in transient cerebral ischemia
27. Platelets thromboembolism and mitral valve prolapse
28. Mitral valve prolapse in women with oral-contraceptive related cerebrovascular insufficiency Associated persistent hypercoagulable state